vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and MANGOCEUTICALS, INC. (MGRX). Click either name above to swap in a different company.
CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $94.4K, roughly 83.1× MANGOCEUTICALS, INC.). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -2935.1%, a 2886.4% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -10.3%). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -33.6%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
MANGOCEUTICALS, INC. is a men's health and personal care company that develops, manufactures, and distributes science-backed consumer products, including dietary supplements, skincare, and hair care solutions targeted at common male wellness needs. It mainly operates in the U.S. market, selling via direct-to-consumer e-commerce platforms and select retail partners, prioritizing accessible, transparent wellness offerings for adult male consumers.
CCEL vs MGRX — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $94.4K |
| Net Profit | $-3.8M | $-2.8M |
| Gross Margin | 77.9% | 50.3% |
| Operating Margin | -50.6% | -389.7% |
| Net Margin | -48.7% | -2935.1% |
| Revenue YoY | -2.3% | -10.3% |
| Net Profit YoY | -105.1% | -42.1% |
| EPS (diluted) | $-0.46 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $94.4K | ||
| Q3 25 | $7.8M | $84.2K | ||
| Q2 25 | $7.9M | $168.1K | ||
| Q1 25 | $8.0M | $109.3K | ||
| Q4 24 | $8.0M | $105.2K | ||
| Q3 24 | $8.1M | $133.4K | ||
| Q2 24 | $8.0M | $163.2K | ||
| Q1 24 | $7.9M | $214.1K |
| Q4 25 | $-3.8M | $-2.8M | ||
| Q3 25 | $749.4K | $-7.6M | ||
| Q2 25 | $355.8K | $-5.4M | ||
| Q1 25 | $282.9K | $-4.8M | ||
| Q4 24 | $-1.9M | $-1.9M | ||
| Q3 24 | $1.1M | $-2.0M | ||
| Q2 24 | $655.8K | $-2.4M | ||
| Q1 24 | $556.2K | $-2.4M |
| Q4 25 | 77.9% | 50.3% | ||
| Q3 25 | 77.0% | 60.4% | ||
| Q2 25 | 76.6% | 53.5% | ||
| Q1 25 | 75.1% | 56.8% | ||
| Q4 24 | 78.4% | 76.1% | ||
| Q3 24 | 73.6% | 62.0% | ||
| Q2 24 | 74.8% | 42.8% | ||
| Q1 24 | 73.7% | 68.8% |
| Q4 25 | -50.6% | -389.7% | ||
| Q3 25 | 24.3% | -8953.5% | ||
| Q2 25 | 18.8% | -3134.0% | ||
| Q1 25 | 13.3% | -4440.0% | ||
| Q4 24 | -1.5% | -1594.0% | ||
| Q3 24 | 17.2% | -1318.2% | ||
| Q2 24 | 17.3% | -1329.1% | ||
| Q1 24 | 10.5% | -1105.9% |
| Q4 25 | -48.7% | -2935.1% | ||
| Q3 25 | 9.6% | -9042.8% | ||
| Q2 25 | 4.5% | -3221.6% | ||
| Q1 25 | 3.5% | -4427.4% | ||
| Q4 24 | -23.2% | -1851.2% | ||
| Q3 24 | 13.0% | -1499.0% | ||
| Q2 24 | 8.2% | -1465.4% | ||
| Q1 24 | 7.1% | -1105.9% |
| Q4 25 | $-0.46 | $0.38 | ||
| Q3 25 | $0.09 | $-0.69 | ||
| Q2 25 | $0.04 | $-0.57 | ||
| Q1 25 | $0.03 | $-1.29 | ||
| Q4 24 | $-0.23 | $-0.79 | ||
| Q3 24 | $0.13 | $-1.14 | ||
| Q2 24 | $0.08 | $-1.37 | ||
| Q1 24 | $0.07 | $-1.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $1.5M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $15.2M |
| Total Assets | $61.7M | $16.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $1.5M | ||
| Q3 25 | $3.2M | $481.3K | ||
| Q2 25 | $4.4M | $101.0K | ||
| Q1 25 | $3.5M | $76.5K | ||
| Q4 24 | $3.5M | $58.7K | ||
| Q3 24 | $2.1M | $73.9K | ||
| Q2 24 | $1.5M | $490.2K | ||
| Q1 24 | $979.6K | $15.3K |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $15.2M | ||
| Q3 25 | $-14.8M | $15.7M | ||
| Q2 25 | $-15.6M | $19.2M | ||
| Q1 25 | $-14.7M | $20.3M | ||
| Q4 24 | $-13.2M | $13.9M | ||
| Q3 24 | $-9.6M | $13.4M | ||
| Q2 24 | $-10.7M | $13.8M | ||
| Q1 24 | $-10.3M | $-958.4K |
| Q4 25 | $61.7M | $16.1M | ||
| Q3 25 | $63.2M | $16.5M | ||
| Q2 25 | $64.4M | $20.8M | ||
| Q1 25 | $64.4M | $21.8M | ||
| Q4 24 | $64.7M | $15.4M | ||
| Q3 24 | $62.9M | $14.8M | ||
| Q2 24 | $62.6M | $15.2M | ||
| Q1 24 | $61.7M | $301.4K |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $-1.1M |
| Free Cash FlowOCF − Capex | $1.2M | — |
| FCF MarginFCF / Revenue | 15.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $-1.1M | ||
| Q3 25 | $2.5M | $-1.2M | ||
| Q2 25 | $707.0K | $-1.3M | ||
| Q1 25 | $954.1K | $-2.3M | ||
| Q4 24 | $2.2M | $-1.1M | ||
| Q3 24 | $2.4M | $-1.2M | ||
| Q2 24 | $1.8M | $-1.6M | ||
| Q1 24 | $-356.9K | $-991.1K |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $644.6K | — | ||
| Q1 25 | $892.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | — |
| Q4 25 | 15.5% | — | ||
| Q3 25 | 31.9% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
